{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:06:24Z","timestamp":1788671184951,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00384-020-03525-x","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T12:02:37Z","timestamp":1581681757000},"page":"719-725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-2502","authenticated-orcid":false,"given":"Omar","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"issue":"1","key":"3525_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1186\/s12885-019-6074-6","volume":"19","author":"MJ Al-Husseini","year":"2019","unstructured":"Al-Husseini MJ, Saad AM, Mohamed HH, Alkhayat MA, Sonbol MB, Abdel-Rahman O (2019) Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria. BMC Cancer 19(1):863. https:\/\/doi.org\/10.1186\/s12885-019-6074-6","journal-title":"BMC Cancer"},{"issue":"3","key":"3525_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.6004\/jnccn.2017.0036","volume":"15","author":"AB Benson 3rd","year":"2017","unstructured":"Benson AB 3rd, Venook AP, Cederquist L, Chan E, Chen YJ, Cooper HS et al (2017) Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 15(3):370\u2013398","journal-title":"J Natl Compr Cancer Netw"},{"issue":"13","key":"3525_CR3","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1016\/j.ejca.2013.04.032","volume":"49","author":"CJ van de Velde","year":"2013","unstructured":"van de Velde CJ, Aristei C, Boelens PG, Beets-Tan RG, Blomqvist L, Borras JM, van den Broek C, Brown G, Coebergh JW, Cutsem EV, Espin E, Gore-Booth J, Glimelius B, Haustermans K, Henning G, Iversen LH, Han van Krieken J, Marijnen CA, Mroczkowski P, Nagtegaal I, Naredi P, Ortiz H, P\u00e5hlman L, Quirke P, R\u00f6del C, Roth A, Rutten HJ, Schmoll HJ, Smith J, Tanis PJ, Taylor C, Wibe A, Gambacorta MA, Meldolesi E, Wiggers T, Cervantes A, Valentini V, European Registration of Cancer Care (2013) EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. Eur J Cancer 49(13):2784\u20132790. https:\/\/doi.org\/10.1016\/j.ejca.2013.04.032","journal-title":"Eur J Cancer"},{"issue":"1","key":"3525_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12957-018-1554-8","volume":"17","author":"M Leimk\u00fchler","year":"2019","unstructured":"Leimk\u00fchler M, Hemmer PHJ, Reyners AKL, de Groot DJA, van Ginkel RJ, Been LB et al (2019) Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study. World J Surg Oncol 17(1):14. https:\/\/doi.org\/10.1186\/s12957-018-1554-8","journal-title":"World J Surg Oncol"},{"issue":"1","key":"3525_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12957-018-1369-7","volume":"16","author":"AE Canda","year":"2018","unstructured":"Canda AE, Arslan C, Terzi C, Sokmen S, Yavuzsen T, Ozkardesler S, Unlu M, Obuz F, Fuzun M (2018) Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy. World J Surg Oncol 16(1):70. https:\/\/doi.org\/10.1186\/s12957-018-1369-7","journal-title":"World J Surg Oncol"},{"issue":"3","key":"3525_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/17474124.2017.1284586","volume":"11","author":"S El-Nakeep","year":"2017","unstructured":"El-Nakeep S, Rashad N, Oweira H, Schmidt J, Helbling D, Giryes A et al (2017) Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review. Expert Rev Gastroenterol Hepatol 11(3):249\u2013258. https:\/\/doi.org\/10.1080\/17474124.2017.1284586","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3525_CR7","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Custom Data (with additional treatment fields), Nov 2018 Sub (1975-2016 varying) - Linked To County Attributes - Total U.S., 1969-2017 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2019, based on the November 2018 submission"},{"key":"3525_CR8","doi-asserted-by":"publisher","unstructured":"Abdel-Rahman O (2019) Effect of body mass index on 5-FU-based chemotherapy toxicity and efficacy among patients with metastatic colorectal cancer; a pooled analysis of 5 randomized trials. Clin Colorectal Cancer. https:\/\/doi.org\/10.1016\/j.clcc.2019.07.005","DOI":"10.1016\/j.clcc.2019.07.005"},{"issue":"2","key":"3525_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.clcc.2018.12.006","volume":"18","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O (2019) Impact of sex on chemotherapy toxicity and efficacy among patients with metastatic colorectal cancer: pooled analysis of 5 randomized trials. Clin Colorectal Cancer 18(2):110\u20135.e2. https:\/\/doi.org\/10.1016\/j.clcc.2018.12.006","journal-title":"Clin Colorectal Cancer"},{"issue":"1","key":"3525_CR10","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.clcc.2018.09.008","volume":"18","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O (2019) Prognostic value of baseline ALBI score among patients with colorectal liver metastases: a pooled analysis of two randomized trials. Clin Colorectal Cancer 18(1):e61\u2013ee8. https:\/\/doi.org\/10.1016\/j.clcc.2018.09.008","journal-title":"Clin Colorectal Cancer"},{"issue":"5","key":"3525_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/jso.23749","volume":"110","author":"S Ahmed","year":"2014","unstructured":"Ahmed S, Stewart JH, Shen P, Votanopoulos KI, Levine EA (2014) Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis. J Surg Oncol 110(5):575\u2013584. https:\/\/doi.org\/10.1002\/jso.23749","journal-title":"J Surg Oncol"},{"issue":"9","key":"3525_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.ejso.2013.06.001","volume":"39","author":"S Riss","year":"2013","unstructured":"Riss S, Mohamed F, Dayal S, Cecil T, Stift A, Bachleitner-Hofmann T, Moran B (2013) Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 39(9):931\u2013937. https:\/\/doi.org\/10.1016\/j.ejso.2013.06.001","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3525_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40880-019-0361-0","volume":"39","author":"C Luo","year":"2019","unstructured":"Luo C, Cen S, Ding G, Wu W (2019) Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commu 39(1):13. https:\/\/doi.org\/10.1186\/s40880-019-0361-0","journal-title":"Cancer Commu"},{"issue":"1","key":"3525_CR14","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.3747\/co.24.3410","volume":"24","author":"JS Quirt","year":"2017","unstructured":"Quirt JS, Nanji S, Wei X, Flemming JA, Booth CM (2017) Is there a sex effect in colon cancer? Disease characteristics, management, and outcomes in routine clinical practice. Curr Oncol 24(1):e15\u2013e23. https:\/\/doi.org\/10.3747\/co.24.3410","journal-title":"Curr Oncol"},{"issue":"1","key":"3525_CR15","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1186\/s12885-018-4786-7","volume":"18","author":"A White","year":"2018","unstructured":"White A, Ironmonger L, Steele RJC, Ormiston-Smith N, Crawford C, Seims A (2018) A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer 18(1):906. https:\/\/doi.org\/10.1186\/s12885-018-4786-7","journal-title":"BMC Cancer"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03525-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-020-03525-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03525-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T21:08:32Z","timestamp":1613250512000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-020-03525-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["3525"],"URL":"https:\/\/doi.org\/10.1007\/s00384-020-03525-x","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"5 February 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were following the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As this study is based on a publicly available database without identifying patient information, informed consent was not needed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}